A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ALS-L1023 in Non-Alcoholic Fatty Liver Disease

Preclinical data have shown that the herbal extract, ALS-L1023, from Melissa officinalis reduces visceral fat and hepatic steatosis. We aimed to assess the safety and efficacy of ALS-L1023 as the treatment of non-alcoholic fatty liver disease (NAFLD). We conducted a 24-week randomized, double-blind,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gi-Ae, Cho, Hyun Chin, Jeong, Soung Won, Kang, Bo-Kyeong, Kim, Mimi, Jung, Seungwon, Hwang, Jungwook, Yoon, Eileen L., Jun, Dae Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142612/
https://www.ncbi.nlm.nih.gov/pubmed/37111380
http://dx.doi.org/10.3390/ph16040623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142612/
https://www.ncbi.nlm.nih.gov/pubmed/37111380
http://dx.doi.org/10.3390/ph16040623

Ejemplares similares